Navigation Links
WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
Date:4/30/2009

Earnings Conference Call to be Held on May 15, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong)

SHANGHAI, May 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2009 on May 15, 2009 Shanghai time, and after the U.S. market closes on Thursday, May 14, 2009 New York time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Friday, May 15, 2009, to discuss its 2009 first-quarter financial results and recent business activities. The conference call may be accessed by calling:

        United States: 1-866-519-4004
        China (Landline): 800-819-0121
        China (Mobile): 400-620-8038
        Hong Kong: 800-933-053
        United Kingdom: 0-808-234-6646
        International: +65-6735-7955
        Conference ID: 96870349
        Web PIN: 8656

A telephone replay will be available two hours after the call's completion at:

        United States: 1-866-214-5335
        China North: 10-800-714-0386
        China South: 10-800-140-0386
        Hong Kong: 800-901-596
        United Kingdom: 0-800-731-7846
        International: +61-2-8235-5000
        P
'/>"/>
SOURCE  WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related biology technology :

1. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
2. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
3. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
4. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
5. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
6. Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value
7. WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
8. Pharmatech 2.0: Introducing Pharmatech Oncology
9. WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
10. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
11. WuXi PharmaTech Announces Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013   NineSigma , Inc., of ... its launch, NineSights.com is now the innovation ... the worldwide community of innovators. From technology ... experts, NineSights stands out for its large community of ... technical disciplines, all vetted by NineSigma. The community is ...
(Date:6/19/2013)... 19, 2013 Biotechnology industry pioneer Amgen ... software provider BlackLine Systems  and enterprise application software ... for a webinar next week entitled "No Account Left ... and SAP to Help Keep Its Account Reconciliations in Good ... The webinar, geared at finance, accounting, audit ...
(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, ,     Recent ...     Immediate and long term impacts ,     Foreseeable ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of DrugCheck® ... has received Class III medical device license approval from ... NxStep Onsite Drug Screen Cup in Canada. Class ... in near-patient settings, such as physicians’ offices. , The ... Class III approval for 24 different drugs and detection ...
Breaking Biology Technology:NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... University in St. Louis have developed a technique for ... and two to five times more effective than commercial ... effective fuel cell technology, which has been waiting in ... for cleaner use of fuels worldwide. , Younan ...
... WA and VANCOUVER, May 14 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... release of two abstracts to be presented during oral ... (ASCO) Annual Meeting. Abstracts are now available to the ... www.oncogenex.com in addition to the ASCO Web site, ...
... Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. ... than 65 studies evaluating the use of Nexavar(R) (sorafenib) ... of Clinical Oncology (ASCO) annual meeting."Nexavar has a proven ... of unresectable hepatocellular carcinoma (HCC), or liver cancer, and ...
Cached Biology Technology:New fuel cell catalyst uses 2 metals 2New fuel cell catalyst uses 2 metals 3OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 2OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 3OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 4OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
(Date:6/18/2013)... A team of internationally recognized feline experts including veterinarians ... the University of Lincoln, U.K. and Dr Ilona Rodan, ... by the International Society of Feline Medicine (ISFM) and ... guidelines for veterinarians, owners and those working with cats ... domestic cat. The new guidelines appear in the ...
(Date:6/17/2013)... Boston, MA Women in the U.S. exposed to high ... as likely to have a child with autism as women ... new study from Harvard School of Public Health (HSPH). It ... autism and air pollution across the U.S. , "Our findings ... of the women in our study lived in areas where ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... made to enhance memory appears to trigger a natural mechanism ... after the drug itself has left the body, according to ... Lynch, along with Associate Researcher Julie Lauterborn, were among a ... class of drugs known as ampakines. Ampakines were developed in ...
... widely used group of insecticides can mix with and ... according to a new study led by biologists at ... in toxicity was relatively modest, the effects from the ... The study's results, reported in the July 26 online ...
... MD, so overjoyed are they at hearing her words. What ... Indulge your passion for spicy cuisine. Drink red wine. Enjoy ... breakfast and, what the heck, eat a grapefruit, too. Gerson ... support the notion that eating these foods will make heartburn ...
Cached Biology News:Drug triggers body's mechanism to reverse aging effect on memory process 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 2Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 3Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 4
... is a small and sensitive single ... both LC and IC. It features a ... Ionization (API) source for outstanding sensitivity and ... with existing LC and IC methods, especially ...
Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....
...
... R&D Systems Cell and Tissue Staining Kits ... a broad range of histological and cytological ... primary IgG antibodies manufactured by either R&D ... is based on the formation of the ...
Biology Products: